In pairwise comparisons, HIF-1α concentration was significantly reduced during STM treatment in the 400 mg group (median difference −4% (95% CI −8– −2%); p<0.001 versus placebo) whereas the difference to placebo did not reach statistical significance in the 200 mg group ( figure 2b ).
← all excerpts
The effect of sulthiame on potential biomarkers in moderate to severe obstructive sleep apnoea.
1
—
—